Semaglutide and tirzepatide programs with real medical oversight — monthly check-ins, transparent pricing, and a plan for the long term. Through Summer House Medspa in Uptown Dallas.
Programs offered through Summer House Medspa · Dr. Daniel Kim, MD · Dallas, TX
14–22%
Average body weight loss in clinical trials
Once/week
Injection frequency — both semaglutide and tirzepatide
Physician-led
Monthly check-ins, not just a prescription
Uptown Dallas
In-person care at Summer House Medspa
GLP-1 medications like semaglutide and tirzepatide work by mimicking gut hormones that regulate appetite and blood sugar. They reduce hunger, slow digestion, and improve insulin sensitivity — producing clinically meaningful weight loss in most patients who complete a full program.
A prescription alone is not a program. The results in the clinical trials — 14 to 22 percent body weight lost — came from structured programs with consistent titration, active side-effect management, and behavioral support. Patients who receive a vial and no oversight have significantly worse outcomes.
Our programs at Summer House Medspa include physician oversight from Dr. Daniel Kim, MD — monthly check-ins, lab monitoring, side-effect management, and an explicit plan for what happens when you reach your goal.
Both are effective. The right choice depends on your goals, health history, insurance, and tolerance. We help you decide at consultation.
Semaglutide — the active ingredient in Wegovy and Ozempic — has the longest real-world track record in GLP-1 weight management. Clinical trials showed average weight loss of ~14–15% of body weight at 68 weeks. The right starting point for most patients.
~14–15% body weight lost
Tirzepatide — Zepbound and Mounjaro — activates two hormonal pathways (GLP-1 + GIP) for stronger appetite suppression. Clinical trials showed average weight loss of 20–22%. The stronger option for patients who want maximum results or who have plateaued on semaglutide.
~20–22% body weight lost
Comprehensive intake: labs, health history, body composition. We understand your full picture before recommending anything.
Your physician maps your starting dose, titration schedule, and program milestones. No generic protocols.
Active monitoring during the loss phase. Side effects are managed as they arise — not after you've already quit.
Your exit strategy is built from day one — not figured out when you hit your goal weight.
What is a GLP-1 weight loss program in Dallas?
A GLP-1 weight loss program uses medications like semaglutide (Wegovy/Ozempic) or tirzepatide (Zepbound/Mounjaro) under physician supervision to reduce appetite and support significant weight loss. Programs at Summer House Medspa include a baseline health assessment, personalized titration schedule, monthly check-ins, and a structured plan for maintenance.
Where can I get semaglutide in Dallas?
Summer House Medspa in Uptown Dallas offers physician-supervised semaglutide weight loss programs. Programs include medical assessment, dose titration, ongoing monitoring, and support — not just a prescription. Book a consultation at summerhousemedspa.com.
What is the difference between semaglutide and tirzepatide?
Semaglutide (Wegovy) activates one receptor (GLP-1) and produces average weight loss of around 14-15% of body weight. Tirzepatide (Zepbound) activates two receptors (GLP-1 and GIP) and produces average weight loss of 20-22% in clinical trials. Tirzepatide is generally more potent but may have more pronounced early side effects. The right choice depends on your health history, goals, insurance coverage, and tolerance.
How much does a GLP-1 weight loss program cost in Dallas?
Medication cost varies: brand-name Wegovy or Zepbound runs $1,300-$1,600/month without insurance. Some commercial insurance plans cover these medications with prior authorization. Manufacturer savings programs can reduce cost to as low as $25/month for eligible patients. Program oversight fees are separate from medication cost. Summer House provides a full cost breakdown at consultation.
How quickly do you lose weight on semaglutide or tirzepatide?
Most patients begin losing weight within the first 4-8 weeks as the medication takes effect. The active weight-loss phase typically runs 6-16 months, with average results of 14% body weight loss on semaglutide and 20-22% on tirzepatide in clinical trials. Individual results depend on starting dose, titration schedule, diet, activity level, and program support.
Schedule a consultation at Summer House Medspa in Uptown Dallas. We’ll review your candidacy, explain your options, and give you a full cost picture — no pressure.
Book a Consultation at Summer House